drugset / Trial / NCT05360342

Incorporation of Vitamin K Into Uremic Lipoproteins

NCT05360342 ↗

Completed 20 enrolled RWTH Aachen University
NaSingle-groupOpen-labelBasic science

Summary

Chronic kidney disease (CKD) patients have an increased cardiovascular risk with corresponding cardiovascular calcifications. CKD patients exhibit a functional vitamin K deficiency. Calcification can be prevented by vitamin K intake. The aim of this study is to investigate the cause for the vitamin K deficiency beyond a diminished dietary vitamin K uptake.

Timeline

Start
2020-03-31
Primary completion
2021-07-15
Completion
2021-09-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Menatetrenone Unknown 1000 ug —
Subject Vitamin K1 Unknown 1000 ug —
Subject menaquinone-7 Unknown 200 ug —